Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
Authors:
Open Access
- 1 January 2017
- journal article
- review article
- Published by XMLink in Chonnam Medical Journal
- Vol. 53 (1) , 14-27
Abstract
Lekshmi KM, et al. Chonnam Med J. 2017 Jan;53(1):14-27. https://doi.org/10.4068/cmj.2017.53.1.14Keywords
This publication has 89 references indexed in Scilit:
- Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating ConditionsPLOS ONE, 2012
- Local gene delivery via endovascular stents coated with dodecylated chitosan–plasmid DNA nanoparticlesInternational Journal of Nanomedicine, 2010
- Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosisBioMedical Engineering OnLine, 2010
- Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fieldsProceedings of the National Academy of Sciences, 2010
- MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion FormationCirculation Research, 2009
- Human Placental Ectonucleoside Triphosphate Diphosphohydrolase Gene Transfer via Gelatin-Coated Stents Prevents In-Stent ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle PhenotypeJournal of Biological Chemistry, 2009
- Cardiovascular gene delivery: The good road is awaiting☆Advanced Drug Delivery Reviews, 2006
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987
- Transluminal Treatment of Arteriosclerotic ObstructionCirculation, 1964